Inspire Medical Systems, Inc. to Present at the Wells Fargo 2025 Healthcare Conference
Inspire Medical Systems (NYSE:INSP), a medical technology company specializing in minimally invasive solutions for obstructive sleep apnea, has announced its participation in the upcoming Wells Fargo 2025 Healthcare Conference.
The company's management team will deliver their presentation on Wednesday, September 3, 2025, at 11:00 a.m. Eastern Time. Investors can access the presentation through a live webcast, with a replay available for two weeks afterward on the company's investor website at investors.inspiresleep.com.
Inspire Medical Systems (NYSE:INSP), azienda di tecnologia medica specializzata in soluzioni minimamente invasive per l'apnea ostruttiva del sonno, ha annunciato la propria partecipazione alla Wells Fargo 2025 Healthcare Conference.
Il team dirigente terr脿 la presentazione mercoled矛 3 settembre 2025 alle 11:00 AM Eastern Time. Gli investitori potranno seguire la presentazione tramite webcast live; la registrazione sar脿 disponibile in replay per due settimane sul sito investor dell'azienda all'indirizzo investors.inspiresleep.com.
Inspire Medical Systems (NYSE:INSP), empresa de tecnolog铆a m茅dica especializada en soluciones m铆nimamente invasivas para la apnea obstructiva del sue帽o, ha anunciado su participaci贸n en la Wells Fargo 2025 Healthcare Conference.
El equipo directivo ofrecer谩 su presentaci贸n el mi茅rcoles 3 de septiembre de 2025 a las 11:00 a.m., hora del Este. Los inversores podr谩n acceder a la presentaci贸n mediante una retransmisi贸n en directo; la grabaci贸n estar谩 disponible para reproducci贸n durante dos semanas en el sitio de inversores de la compa帽铆a en investors.inspiresleep.com.
Inspire Medical Systems (NYSE:INSP), 韽愳噭靹� 靾橂┐氍错樃頋§鞐� 雽�頃� 斓滌唽旃姷 靻旊（靺橃潉 鞝勲鞙茧 頃橂姅 鞚橂旮办垹 旮办梾鞚� Wells Fargo 2025 Healthcare Conference鞐� 彀戈皜頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟.
瓴届榿歆勋潃 2025雲� 9鞗� 3鞚� 靾橃殧鞚� 霃欕秬 響滌鞁� 旮办 鞓れ爠 11鞁�鞐� 氚滍憸毳� 歆勴枆頃� 鞓堨爼鞛呺媹雼�. 韴瀽鞛愲摛鞚� 霛检澊敫� 鞗轨簮鞀ろ姼搿� 氚滍憸毳� 鞁滌箔頃� 靾� 鞛堨溂氅�, 須岇偓 韴瀽鞛� 鞗轨偓鞚错姼 investors.inspiresleep.com鞐愳劀 氚滍憸 膦呺 頉� 2欤缄皠 鞛儩 鞓侅儊鞚� 氤� 靾� 鞛堨姷雼堧嫟.
Inspire Medical Systems (NYSE:INSP), une soci茅t茅 de technologie m茅dicale sp茅cialis茅e dans les solutions mini-invasives pour l'apn茅e obstructive du sommeil, a annonc茅 sa participation 脿 la Wells Fargo 2025 Healthcare Conference.
L'茅quipe de direction pr茅sentera le mercredi 3 septembre 2025 脿 11h00, heure de l'Est. Les investisseurs pourront suivre la pr茅sentation via un webdiffusion en direct ; une rediffusion sera disponible pendant deux semaines sur le site investisseurs de la soci茅t茅 脿 l'adresse investors.inspiresleep.com.
Inspire Medical Systems (NYSE:INSP), ein Medizintechnikunternehmen, das sich auf minimalinvasive L枚sungen f眉r obstruktive Schlafapnoe spezialisiert hat, hat seine Teilnahme an der Wells Fargo 2025 Healthcare Conference angek眉ndigt.
Das Managementteam wird seine Pr盲sentation am Mittwoch, den 3. September 2025, um 11:00 Uhr Eastern Time halten. Investoren k枚nnen die Pr盲sentation per Live-Webcast verfolgen; ein Replay steht anschlie脽end f眉r zwei Wochen auf der Investorenseite des Unternehmens unter investors.inspiresleep.com zur Verf眉gung.
- None.
- None.
MINNEAPOLIS, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Wells Fargo 2025 Healthcare Conference on Wednesday, September 3, 2025.
Inspire is scheduled to present at 11:00 a.m. Eastern Time. The presentation will be accessible via a live webcast .
A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire鈥檚 Investor website at .
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire鈥檚 proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit .
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
617-549-2443
FAQ
When is Inspire Medical Systems (INSP) presenting at the Wells Fargo Healthcare Conference 2025?
How can investors access Inspire Medical Systems' Wells Fargo conference presentation?
What does Inspire Medical Systems (INSP) specialize in?
How long will the webcast replay be available for INSP's Wells Fargo conference presentation?
